EFFECTS OF 5-HT1A RECEPTOR LIGANDS ON A SAFETY SIGNAL WITHDRAWAL PROCEDURE OF CONFLICT IN THE RAT

被引:32
作者
CHARRIER, D
DANGOUMAU, L
HAMON, M
PUECH, AJ
THIEBOT, MH
机构
[1] INSERM,U288,F-75634 PARIS 13,FRANCE
[2] UNIV PARIS 06,DEPT PHARMACOL,F-75634 PARIS 13,FRANCE
关键词
5-HT1A RECEPTOR AGONISTS; PARTIAL AGONISTS AND ANTAGONISTS; ANXIETY; BEHAVIORAL SUPPRESSION; RAT;
D O I
10.1016/0091-3057(94)90528-2
中图分类号
B84 [心理学]; C [社会科学总论]; Q98 [人类学];
学科分类号
03 ; 0303 ; 030303 ; 04 ; 0402 ;
摘要
The present study evaluated in the rat the ability of various 5-HT1A receptor agonists to exert an ''anxiolytic-like'' release of the suppression of lever pressing for food induced by the withdrawal of a conditioned signal for safety without presentation of a conditioned signal for punishment. During the period associated with the safety signal withdrawal (Saf.CS-/Pun.CS-), control rats exhibited a typical pattern of responding with an initial strong blockade of responding that lessened over the period as presses were rewarded and shocks omitted. The 5-HT1A receptor partial agonists buspirone (0.125-0.5 mg/kg) and 8-(2-[2,3-dihydro-1,4-benzodioxin-2-yl-methylamino]ethyl)-8-azaspiro[4,5]decane-7,9-dione methyl sulfonate (MDL 73005EF; 0.5-2 mg/kg) and the full agonist (+)4-[N-(5-methoxy-chroman-3-yl)-N-propylamino]-butyl-8-azaspiro[4,5]decane-7,9-dione (S 20499; 0.125-1 mg/kg) produced a robust and dose-related release of pressing during the Saf.CS-/Pun.CS- period. This effect was less marked with ipsapirone (0.125-1 mg/kg). Conversely, 8-hydroxy-2-(di-n-propylamino)tetralin (8-OH-DPAT; 0.06-0.25 mg/kg), a full agonist, was completely inactive and did not prevent MDL 73005EF (1-2 mg/kg) or diazepam (0.125 mg/kg) from releasing the suppressed behavior. The specific 5-HT1A antagonist (+)-N-tert-butyl-3-4-(2-methoxyphenyl)piperazin-1-yl-2-phenylpropanamide [(+)-WAY 100135; 0.25-8 mg/kg] and the beta-adrenoceptor/5-HT1A antagonist (-)-tertatolol (2-8 mg/kg) did not modify the behavioral blockade, nor did (+)-WAY 100135 (2-4 mg/kg) reduce the ability of buspirone (0.25 mg/kg) to enhance responding during the Saf.CS-/Pun.CS period. Finally, neither 1-(2-pyrimidinyl)piperazine (1-PP), the common metabolite of azapirones, with alpha(2)-adrenoceptor antagonist properties, nor the D-2-receptor antagonist l-sulpiride reduced the behavioral suppression. These data suggest that the activation of somatodendritic and/or postsynaptic 5-HT1A receptors does not entirely account for the anxiolytic-like effects of 5-HT1A agonists in this procedure of conflict in the rat.
引用
收藏
页码:281 / 289
页数:9
相关论文
共 51 条
[1]   BLOCKADE OF ALPHA-2-ADRENOCEPTORS BY 1-(2-PYRIMIDINYL)-PIPERAZINE (PMP) INVIVO AND ITS RELATION TO THE ACTIVITY OF BUSPIRONE [J].
BIANCHI, G ;
GARATTINI, S .
EUROPEAN JOURNAL OF PHARMACOLOGY, 1988, 147 (03) :343-350
[2]   EVIDENCE THAT CENTRAL 5-HYDROXYTRYPTAMINERGIC NEURONS ARE INVOLVED IN THE ANXIOLYTIC ACTIVITY OF BUSPIRONE [J].
CARLI, M ;
PRONTERA, C ;
SAMANIN, R .
BRITISH JOURNAL OF PHARMACOLOGY, 1989, 96 (04) :829-836
[3]   ANIMAL-MODELS OF ANXIETY - THE EFFECT OF COMPOUNDS THAT MODIFY 5-HT NEUROTRANSMISSION [J].
CHOPIN, P ;
BRILEY, M .
TRENDS IN PHARMACOLOGICAL SCIENCES, 1987, 8 (10) :383-388
[4]   ACUTE ADMINISTRATION OF DIAZEPAM AND BUSPIRONE IN RATS TRAINED ON CONFLICT SCHEDULES HAVING DIFFERENT DEGREES OF PREDICTABILITY [J].
COSTELLO, NL ;
CARLSON, JN ;
GLICK, SD .
PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR, 1991, 40 (04) :787-794
[5]   ELECTROPHYSIOLOGICAL EVIDENCE FOR A LARGE RECEPTOR RESERVE FOR INHIBITION OF DORSAL RAPHE NEURONAL FIRING BY 5-HT(1A) AGONISTS [J].
COX, RF ;
MELLER, E ;
WASZCZAK, BL .
SYNAPSE, 1993, 14 (04) :297-304
[6]   ACTIONS AND SOME INTERACTIONS OF 5-HT1A LIGANDS IN THE ELEVATED X-MAZE AND EFFECTS OF DORSAL RAPHE LESIONS [J].
CRITCHLEY, MAE ;
NJUNGE, K ;
HANDLEY, SL .
PSYCHOPHARMACOLOGY, 1992, 106 (04) :484-490
[7]   SEROTONIN DOES NOT MEDIATE ANXIOLYTIC EFFECTS OF BUSPIRONE IN THE FEAR-POTENTIATED STARTLE PARADIGM - COMPARISON WITH 8-OH-DPAT AND IPSAPIRONE [J].
DAVIS, M ;
CASSELLA, JV ;
KEHNE, JH .
PSYCHOPHARMACOLOGY, 1988, 94 (01) :14-20
[8]  
DEVIVO M, 1986, J PHARMACOL EXP THER, V238, P248
[9]   SEROTONERGIC MECHANISMS IN THE BEHAVIORAL-EFFECTS OF BUSPIRONE AND GEPIRONE [J].
EISON, AS ;
EISON, MS ;
STANLEY, M ;
RIBLET, LA .
PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR, 1986, 24 (03) :701-707
[10]   ANTICONFLICT EFFECT OF THE PUTATIVE SEROTONIN RECEPTOR AGONIST 8-HYDROXY-2-(DI-N-PROPYLAMINO)TETRALIN (8-OH-DPAT) [J].
ENGEL, JA ;
HJORTH, S ;
SVENSSON, K ;
CARLSSON, A ;
LILJEQUIST, S .
EUROPEAN JOURNAL OF PHARMACOLOGY, 1984, 105 (3-4) :365-368